Magnetar Financial’s Kindred Biosciences, Inc. KIN Stock Holding History

Magnetar Financial’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,431,998	Closed	-$31.5K	–	1690
2021 Q2	$31.5K	Buy	+3,431,998	New	+$20M	0.3%	60
2018 Q4	–	Sell	-13,209	Closed	-$184K	–	561
2018 Q3	$184K	Buy	+13,209	New	+$179K	﹤0.01%	468

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Magnetar Financial's KIN Position: Q3 2021 in Review

Magnetar Financial sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 3,431,998 shares — an estimated $31.5K sold.

Magnetar Financial first reported a position in KIN in Q3 2018 and held it in 2 quarters. The position peaked at $184K in Q3 2018. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Magnetar Financial reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Magnetar Financial sold 3,431,998 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $31.5K.
Magnetar Financial first reported a position in Kindred Biosciences, Inc. in Q3 2018 and held it in 2 quarters.
Magnetar Financial's Kindred Biosciences, Inc. position peaked at $184K in Q3 2018.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Magnetar Financial's 13F filing for Q3 2021, filed 12 Nov 2021.